Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 218 Clinical Trials
ID/Name Source Type
18-Month Double-Blind, Placebo-Controlled Study of Curcumin
NCT01383161 clinicaltrials.gov Clinical Trial
A 12 Week Randomized, Double Blind, Placebo-Controlled Pilot Study of Davunetide (NAP, AL-108) in Predicted Tauopathies
NCT01056965 clinicaltrials.gov Clinical Trial
A 24-month Randomised Parallel Group Single-blinded Multi-centre Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia
NCT03174886 clinicaltrials.gov Clinical Trial
A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration
NCT00187525 clinicaltrials.gov Clinical Trial
A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
NCT00208819 clinicaltrials.gov Clinical Trial
A Double-blind Placebo Controlled Study of Mixed-amphetamine Salts, Extended Release (Adderall XR) for Cognitive Impairment in MS
NCT02676739 clinicaltrials.gov Clinical Trial
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
NCT03538522 clinicaltrials.gov Clinical Trial
A Non-invasive, Multimodal Approach to Restore Functional Networks and Cognition in Alzheimer's Disease and Frontotemporal Dementia
NCT03422250 clinicaltrials.gov Clinical Trial
A Phase I Study to Evaluate the Single and Multiple-dose Pharmacokinetics of Intravenous Trappsol Cyclo (HP-Beta-CD) in Patients With Niemann-Pick Disease Type C (NPC-1) and the Effects of Dosing Upon Biomarkers of NPC Disease
NCT02939547 clinicaltrials.gov Clinical Trial
A Phase I/II Study to Evaluate the Safety and PK of iv Trappsol Cyclo in Patients With Niemann-Pick Disease Type C NPC-1 and the Pharmacodynamic Effects of Treatment Upon Markers of Cholesterol Metabolism and Clinical Outcomes
NCT02912793 clinicaltrials.gov Clinical Trial